Margaret Foti on Cancer Research
Over the past few decades, we have made significant progress against many forms of cancer. Today, there are nearly 14 million cancer survivors living in the United States, 15 percent of whom were diagnosed 20 or more years ago. There have also been more than 1 million fewer cancer deaths since the early 1990s as a result of declining death rates from cancer.
However, in spite of the progress, cancer, which is a collective term to describe more than 200 different diseases, remains the second most common cause of disease-related death in the U.S., according to the AACR Cancer Progress Report 2013.
The American Association fo...
Source: PHRMA - May 28, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Margaret Foti
CEODr. Margaret Foti is the chief executive officer of the American Association for Cancer Research (AACR). The AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. Under her visionary leadership, its membership has grown to over 34,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates in more than 90 countries.
She is a graduate of Temple University’s School of Communication and Journalism, and is an influential voice in advancing the field of ca...
Source: PHRMA - May 28, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Gwen Darien on Cancer Research
Perhaps the most compelling, as well as the least understood of the evolving models for cancer research and care is patient-centered research and care. As a cancer survivor and long-time advocate, I am often asked to provide the patient perspective in the various venues where patient-centered issues are discussed.
In these venues, the patient is often portrayed, and viewed, as a two-dimensional figure—a flat, faceless cutout at the center of a diagram. Yet, as we all know, patients are multi-dimensional people with diverse values, experiences, and desires who are members of a greater community. We are more than our diagn...
Source: PHRMA - May 28, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Gwen Darien
Executive Vice PresidentGwen Darien is Executive Vice President of Programs and Services where she oversees research, programs, education, and patient and family services.
Prior to joining CSC, Gwen was a director of The Pathways Project—an organization that puts people at the center of health care research and delivery. She served as executive director of the Samuel Waxman Cancer Research Foundation. In this role, she was committed to developing collaborations across all segments of the cancer community to translate research discoveries from the bench to the bedside.
Prior to joining SWCRF, Gwen was editor-in-chief o...
Source: PHRMA - May 28, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Robert Zirkelbach
Sr. Vice President, CommunicationsRobert Zirkelbach is Senior Vice President of Communications at PhRMA. He joins PhRMA in 2014 after working for seven years representing the health insurance industry. He likes Saturday afternoon BBQs on his deck, traveling, trying new restaurants, and attempting to play golf. He’s an avid, somewhat obsessive, Iowa Hawkeye fan and is lucky to have a wife that loves watching college football on Saturday afternoons. Follow Robert on Twitter @robzirk.
@robzirkCatalyst ContributorsCompany: PhRMA (Source: PHRMA)
Source: PHRMA - May 23, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
